Genetic Testing

Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference

MyRisk®, FirstGene®, Prequel®, and Foresight® studies among 10 datasets to be shared by MyriadSALT LAKE CITY, Sept. 18, 2024 (GLOBE…

2 months ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

- Recurring and Accelerated Receipt of Order Reflects Customer Commitment to Linea DNA - STONY BROOK, NY / ACCESSWIRE /…

2 months ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

STONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

2 months ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader…

2 months ago

Tay-Sachs Awareness Month: Prioritize Your Health With Jscreen

ATLANTA, GA / ACCESSWIRE / September 9, 2024 / Shari Ungerleider and Myra Sack have one thing in common: they…

3 months ago

Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library…

3 months ago

Myriad Genetics to Host Investor Event on October 9, 2024

SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…

3 months ago

Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that…

3 months ago